Last edition
News about "Medicines and Healthcare products Regulatory Agenc"
Regulators Warn against Promotion of Newly Licensed Weight-Loss Medicines
MHRA, ASA, and GPhC have warned businesses against promoting newly licensed prescription-only and unlicensed weight-loss medicines, reinforcing compliance with advertising regulations and public health protections.
Medicines And Healthcare Products Regulatory Agenc | 20/06/2026 | By News Bureau
Piramal Pharma Solutions' Grangemouth Facility Receives Updated MHRA GMP Certificates
Piramal Pharma Solutions's Grangemouth facility in the UK has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.
Medicines And Healthcare Products Regulatory Agenc | 19/11/2025 | By Dineshwori | 281
UK Halves Clinical Trial Approval Times Through Major Digital Reforms
Backed by major reforms and new digital platforms at the Medicines and Healthcare products Regulatory Agency (MHRA), the UK has reduced the average clinical trial approval time by more than half — from 91 days to just 41 days.
Medicines And Healthcare Products Regulatory Agenc | 08/10/2025 | By Dineshwori | 286
Marksans Pharma's UK Subsidiary Relonchem Secures Multiple MHRA Approvals
Marksans Pharma's wholly owned UK subsidiary, Relonchem Ltd., has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for Metformin Hydrochloride Relonchem Prolonged Release Tablets in three strengths—500 mg, 750 mg, and 1000 mg.
Medicines And Healthcare Products Regulatory Agenc | 18/08/2025 | By Dineshwori | 526
UK Approves Sanofi's Teplizumab to Delay Onset of Stage 3 Type 1 Diabetes
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield) to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D.
Medicines And Healthcare Products Regulatory Agenc | 18/08/2025 | By Dineshwori | 262
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy